Compare · STAA vs WRBY
STAA vs WRBY
Side-by-side comparison of STAAR Surgical Company (STAA) and Warby Parker Inc. (WRBY): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both STAA and WRBY operate in Ophthalmic Goods (Health Care), so they compete in similar markets.
- WRBY is the larger of the two at $2.79B, about 1.9x STAA ($1.49B).
- Over the past year, STAA is up 74.9% and WRBY is up 1.1% - STAA leads by 73.9 points.
- WRBY has been more active in the news (7 items in the past 4 weeks vs 4 for STAA).
- Both have 25 recent analyst ratings on file.
- Company
- STAAR Surgical Company
- Warby Parker Inc.
- Price
- $30.02+0.50%
- $22.73-5.72%
- Market cap
- $1.49B
- $2.79B
- 1M return
- +8.14%
- +3.22%
- 1Y return
- +74.94%
- +1.09%
- Industry
- Ophthalmic Goods
- Ophthalmic Goods
- Exchange
- NASDAQ
- NYSE
- IPO
- 2021
- News (4w)
- 4
- 7
- Recent ratings
- 25
- 25
STAAR Surgical Company
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone intraocular lenses, as well as preloaded injectors for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. STAAR Surgical Company markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, and Italy. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
Warby Parker Inc.
Warby Parker Inc. designs, manufactures, and retails eyewear products for men and women. It offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, and contact lenses, as well as eye exams and vision tests. As of June 30, 2021, it operated 145 retail stores, which included 142 locations in the United States and 3 locations in Canada, as well as online stores. The company was formerly known as JAND, Inc. and changed its name to Warby Parker Inc. in June 2021. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.
Latest STAA
- STAAR Surgical Announces Participation in Upcoming Investor Conferences
- Chief Development Officer Michna Magda was granted 19,795 shares and covered exercise/tax liability with 9,703 shares, increasing direct ownership by 31% to 42,783 units (SEC Form 4)
- Interim Co-CEO and CFO Andrews Deborah J was granted 15,699 shares and covered exercise/tax liability with 5,632 shares (SEC Form 4)
- Interim Co-CEO and Pres. & COO Foust Warren covered exercise/tax liability with 16,785 shares and was granted 32,990 shares, increasing direct ownership by 24% to 83,112 units (SEC Form 4)
- STAAR Surgical upgraded by Wedbush with a new price target
- SEC Form 10-Q filed by STAAR Surgical Company
- STAAR Surgical Company filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- STAAR Surgical Reports First Quarter 2026 Results; Issues Shareholder Letter
- Interim Co-CEO and Pres. & COO Foust Warren covered exercise/tax liability with 3,448 shares, decreasing direct ownership by 5% to 66,917 units (SEC Form 4)
- Chief Development Officer Michna Magda covered exercise/tax liability with 1,680 shares, decreasing direct ownership by 5% to 32,691 units (SEC Form 4)
Latest WRBY
- Marvell Technology and Flex Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
- Co-Chief Executive Officer Gilboa David Abraham converted options into 20,799 shares and covered exercise/tax liability with 11,505 shares, increasing direct ownership by 18% to 59,587 units (SEC Form 4) (withholding tax)
- Co-Chief Executive Officer Blumenthal Neil Harris converted options into 20,799 shares and covered exercise/tax liability with 11,505 shares, increasing direct ownership by 19% to 59,459 units (SEC Form 4) (tax withholding)
- Amendment: SEC Form SCHEDULE 13G/A filed by Warby Parker Inc.
- Warby Parker Announces Participation in Upcoming 2026 Baird Global Consumer, Technology & Services Conference
- Co-Chief Executive Officer Blumenthal Neil Harris sold $1,893,091 worth of shares (63,040 units at $30.03) as part of a pre-agreed trading plan and converted options into 63,040 shares (SEC Form 4)
- Warby Parker Unveils First Intelligent Eyewear Design
- Director Singer Bradley E sold $715,166 worth of shares (25,000 units at $28.61) (SEC Form 4)
- SEC Form 144 filed by Warby Parker Inc.
- Telsey Advisory Group reiterated coverage on Warby Parker with a new price target